Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism

MLA

J.M. Suriñach, et al. “Management and Outcome of Major Bleeding in Patients Receiving Vitamin K Antagonists for Venous Thromboembolism.” Thrombosis Research, vol. 171, Nov. 2018, pp. 74–80. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1149ea9b9865f78d604029507163d7a&authtype=sso&custid=ns315887.

APA

J.M. Suriñach, F. Pace, Farès Moustafa, Pieter W. Kamphuisen, Ángel Sampériz, Ángeles Blanco-Molina, Joan Carles Sahuquillo, María Alfonso, Manuel Monreal, Alexander Stehouwer, Riete Investigators, & Patrick Mismetti. (2018). Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism. Thrombosis Research, 171, 74–80.

Chicago

J.M. Suriñach, F. Pace, Farès Moustafa, Pieter W. Kamphuisen, Ángel Sampériz, Ángeles Blanco-Molina, Joan Carles Sahuquillo, et al. 2018. “Management and Outcome of Major Bleeding in Patients Receiving Vitamin K Antagonists for Venous Thromboembolism.” Thrombosis Research 171 (November): 74–80. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1149ea9b9865f78d604029507163d7a&authtype=sso&custid=ns315887.